PolyProx

Recent Finacing

Seed

Recent Raise

$1.3M

PolyProx Therapeutics, a University of Cambridge spinout, develops Polyproxin protein‑scaffold therapeutics that link tumor‑targeting entities to cellular degradation triggers to remove hard‑to‑drug oncogenic proteins.